Fixed-cycle oral pomalidomide/lenalidomide-based therapy is associated with durable treatment-free remission in idiopathic multicentric castleman disease with TAFRO syndrome: a single-center retrospective study.
- DOI
- 10.1186/s13023-026-04516-x
- Published
- 2026 Aug 8
- Container
- Orphanet journal of rare diseases
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13023-026-04516-x,
title = {Fixed-cycle oral pomalidomide/lenalidomide-based therapy is associated with durable treatment-free remission in idiopathic multicentric castleman disease with TAFRO syndrome: a single-center retrospective study.},
author = {Bo T and Shuanglian X and Xiaojuan Y and Wei W and Ye S and Mingyi D and Yuhua S and Wei L and Yujun D},
year = {2026},
journal = {Orphanet journal of rare diseases},
doi = {10.1186/s13023-026-04516-x},
url = {https://doi.org/10.1186/s13023-026-04516-x}
}RIS
TY - JOUR TI - Fixed-cycle oral pomalidomide/lenalidomide-based therapy is associated with durable treatment-free remission in idiopathic multicentric castleman disease with TAFRO syndrome: a single-center retrospective study. AU - Bo T AU - Shuanglian X AU - Xiaojuan Y AU - Wei W AU - Ye S AU - Mingyi D AU - Yuhua S AU - Wei L AU - Yujun D PY - 2026 JO - Orphanet journal of rare diseases DO - 10.1186/s13023-026-04516-x UR - https://doi.org/10.1186/s13023-026-04516-x ER -
APA
T, B., X, S., Y, X., W, W., S, Y., D, M., S, Y., L, W., & D, Y. (2026). Fixed-cycle oral pomalidomide/lenalidomide-based therapy is associated with durable treatment-free remission in idiopathic multicentric castleman disease with TAFRO syndrome: a single-center retrospective study.. Orphanet journal of rare diseases. https://doi.org/10.1186/s13023-026-04516-x
Source records
- pubmed · retrieved 2026-11-10T13:29:33.909Z